Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Corvus Pharmaceuticals, Inc. (CRVS) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Corvus Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1626971.
Total stock buying since 2016: $84,140,374.
Total stock sales since 2016: $62,606,353.
Total stock option exercises since 2016: $1,956,755.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,352,664 | $9,784,728 | 559,073 | $1,956,755 |
| 2024 | 597,634 | $1,034,504 | 0 | $0 | 0 | $0 |
| 2023 | 10,000 | $24,500 | 0 | $0 | 0 | $0 |
| 2022 | 174,928 | $213,266 | 0 | $0 | 0 | $0 |
| 2021 | 2,717,142 | $9,469,247 | 7,219,288 | $38,575,461 | 0 | $0 |
| 2020 | 0 | $0 | 1,538,062 | $8,168,302 | 0 | $0 |
| 2019 | 1,675,220 | $6,144,213 | 1,492,956 | $6,077,862 | 0 | $0 |
| 2018 | 3,690,612 | $31,101,089 | 0 | $0 | 0 | $0 |
| 2017 | 55,000 | $573,897 | 0 | $0 | 0 | $0 |
| 2016 | 2,408,464 | $35,579,658 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 0 | $0 | 2,352,664 | $9,784,728 | 0 | $0 |
| 2025-05 | 0 | $0 | 0 | $0 | 559,073 | $1,956,755 |
| 2024-05 | 597,634 | $1,034,504 | 0 | $0 | 0 | $0 |
| 2023-05 | 10,000 | $24,500 | 0 | $0 | 0 | $0 |
| 2022-12 | 20,000 | $15,800 | 0 | $0 | 0 | $0 |
| 2022-09 | 45,000 | $35,374 | 0 | $0 | 0 | $0 |
| 2022-06 | 15,890 | $15,908 | 0 | $0 | 0 | $0 |
| 2022-03 | 94,038 | $146,184 | 0 | $0 | 0 | $0 |
| 2021-10 | 0 | $0 | 2,000,000 | $9,928,000 | 0 | $0 |
| 2021-09 | 0 | $0 | 5,219,288 | $28,647,461 | 0 | $0 |
| 2021-08 | 10,000 | $19,250 | 0 | $0 | 0 | $0 |
| 2021-05 | 35,714 | $99,999 | 0 | $0 | 0 | $0 |
| 2021-02 | 2,671,428 | $9,349,998 | 0 | $0 | 0 | $0 |
| 2020-07 | 0 | $0 | 1,538,062 | $8,168,302 | 0 | $0 |
| 2019-11 | 15,008 | $45,025 | 0 | $0 | 0 | $0 |
| 2019-08 | 292,812 | $1,028,169 | 0 | $0 | 0 | $0 |
| 2019-07 | 118,486 | $463,280 | 1,492,956 | $6,077,862 | 0 | $0 |
| 2019-06 | 1,248,914 | $4,607,739 | 0 | $0 | 0 | $0 |
| 2018-12 | 61,202 | $251,106 | 0 | $0 | 0 | $0 |
| 2018-03 | 3,629,410 | $30,849,983 | 0 | $0 | 0 | $0 |
| 2017-11 | 10,000 | $107,850 | 0 | $0 | 0 | $0 |
| 2017-06 | 45,000 | $466,047 | 0 | $0 | 0 | $0 |
| 2016-06 | 218,766 | $2,794,548 | 0 | $0 | 0 | $0 |
| 2016-05 | 23,032 | $285,120 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-27 | Orbimed Capital Gp V Llc | Sale | 1,176,332 | 4.16 | 4,892,364 |
| 2025-06-27 | Thompson Peter A. | Sale | 1,176,332 | 4.16 | 4,892,364 |
| 2025-05-07 | Miller Richard A Md (President and CEO) | Option Ex | 559,073 | 3.50 | 1,956,755 |
| 2024-05-06 | Jones William Benton (See Remarks) | Buy | 20,000 | 1.73 | 34,620 |
| 2024-05-06 | Miller Richard A Md (President and CEO) | Buy | 577,634 | 1.73 | 999,884 |
| 2023-05-15 | Grais Linda | Buy | 10,000 | 2.45 | 24,500 |
| 2022-12-20 | Jones William Benton (See Remarks) | Buy | 20,000 | .79 | 15,800 |
| 2022-09-28 | Miller Richard A Md (President and CEO) | Buy | 25,000 | .76 | 19,075 |
| 2022-09-20 | Miller Richard A Md (President and CEO) | Buy | 20,000 | .81 | 16,299 |
| 2022-06-27 | Miller Richard A Md (President and CEO) | Buy | 5,000 | 1.00 | 4,985 |
| 2022-06-24 | Miller Richard A Md (President and CEO) | Buy | 5,000 | 1.03 | 5,150 |
| 2022-06-06 | Miller Richard A Md (President and CEO) | Buy | 890 | 1.01 | 898 |
| 2022-06-02 | Miller Richard A Md (President and CEO) | Buy | 5,000 | .97 | 4,875 |
| 2022-03-31 | Miller Richard A Md (President and CEO) | Buy | 15,000 | 1.64 | 24,540 |
| 2022-03-17 | Miller Richard A Md (President and CEO) | Buy | 5,000 | 1.59 | 7,950 |
| 2022-03-17 | Lea Leiv (Chief Financial Officer) | Buy | 13,878 | 1.65 | 22,898 |
| 2022-03-16 | Lea Leiv (Chief Financial Officer) | Buy | 35,160 | 1.54 | 54,146 |
| 2022-03-15 | Miller Richard A Md (President and CEO) | Buy | 25,000 | 1.47 | 36,650 |
| 2021-10-01 | Ecor1 Capital, Llc | Sale | 2,000,000 | 4.96 | 9,928,000 |
| 2021-09-30 | Ecor1 Capital, Llc | Sale | 3,000,000 | 5.04 | 15,131,999 |
| 2021-09-20 | Orbimed Capital Gp V Llc | Sale | 1,109,644 | 6.09 | 6,757,731 |
| 2021-09-20 | Thompson Peter A. | Sale | 1,109,644 | 6.09 | 6,757,731 |
| 2021-08-20 | Miller Richard A Md (President and CEO) | Buy | 10,000 | 1.93 | 19,250 |
| 2021-05-04 | Miller Richard A Md (President and CEO) | Buy | 35,714 | 2.80 | 99,999 |
| 2021-02-17 | Orbimed Capital Gp V Llc | Buy | 1,285,714 | 3.50 | 4,499,999 |
| 2021-02-17 | Thompson Peter A. | Buy | 1,285,714 | 3.50 | 4,499,999 |
| 2021-02-17 | Miller Richard A Md (President and CEO) | Buy | 100,000 | 3.50 | 350,000 |
| 2020-07-08 | Novo Holdings A/s (10% Owner) | Sale | 741,440 | 5.38 | 3,985,240 |
| 2020-07-07 | Novo Holdings A/s (10% Owner) | Sale | 796,622 | 5.25 | 4,183,062 |
| 2019-11-13 | Miller Richard A Md (President and CEO) | Buy | 14,736 | 3.00 | 44,237 |
| 2019-11-12 | Miller Richard A Md (President and CEO) | Buy | 272 | 2.90 | 788 |
| 2019-08-07 | Miller Richard A Md (President and CEO) | Buy | 2,500 | 3.54 | 8,850 |
| 2019-08-06 | Orbimed Capital Gp V Llc | Buy | 142,656 | 3.51 | 500,722 |
| 2019-08-06 | Thompson Peter A. | Buy | 142,656 | 3.51 | 500,722 |
| 2019-08-06 | Miller Richard A Md (President and CEO) | Buy | 5,000 | 3.58 | 17,875 |
| 2019-07-25 | Novo Holdings A/s (10% Owner) | Sale | 1,400,000 | 4.00 | 5,600,000 |
| 2019-07-24 | Novo Holdings A/s (10% Owner) | Sale | 53,240 | 5.01 | 266,732 |
| 2019-07-23 | Novo Holdings A/s (10% Owner) | Sale | 39,716 | 5.32 | 211,130 |
| 2019-07-01 | Orbimed Capital Gp V Llc | Buy | 59,243 | 3.91 | 231,640 |
| 2019-07-01 | Thompson Peter A. | Buy | 59,243 | 3.91 | 231,640 |
| 2019-06-28 | Orbimed Capital Gp V Llc | Buy | 565,178 | 3.72 | 2,102,462 |
| 2019-06-28 | Thompson Peter A. | Buy | 565,178 | 3.72 | 2,102,462 |
| 2019-06-27 | Orbimed Capital Gp V Llc | Buy | 32,923 | 3.34 | 109,962 |
| 2019-06-27 | Thompson Peter A. | Buy | 32,923 | 3.34 | 109,962 |
| 2019-06-14 | Miller Richard A Md (President and CEO) | Buy | 11,657 | 3.40 | 39,668 |
| 2019-06-13 | Miller Richard A Md (President and CEO) | Buy | 343 | 3.52 | 1,207 |
| 2019-06-11 | Miller Richard A Md (President and CEO) | Buy | 6,000 | 3.67 | 22,020 |
| 2019-06-07 | Miller Richard A Md (President and CEO) | Buy | 9,212 | 3.37 | 31,016 |
| 2019-06-07 | Lea Leiv (Chief Financial Officer) | Buy | 10,000 | 3.38 | 33,800 |
| 2019-06-06 | Lea Leiv (Chief Financial Officer) | Buy | 15,500 | 3.56 | 55,180 |
| 2018-12-27 | Miller Richard A Md (President and CEO) | Buy | 20,000 | 3.29 | 65,880 |
| 2018-12-21 | Lea Leiv (Chief Financial Officer) | Buy | 24,700 | 4.15 | 102,406 |
| 2018-12-20 | Miller Richard A Md (President and CEO) | Buy | 10,000 | 4.39 | 43,949 |
| 2018-12-06 | Miller Richard A Md (President and CEO) | Buy | 5,000 | 5.99 | 29,935 |
| 2018-12-04 | Miller Richard A Md (President and CEO) | Buy | 1,502 | 5.95 | 8,936 |
| 2018-03-12 | Orbimed Capital Gp V Llc | Buy | 588,235 | 8.50 | 4,999,997 |
| 2018-03-12 | Gould Terry P (Director) | Buy | 588,235 | 8.50 | 4,999,997 |
| 2018-03-12 | Novo Holdings A/s (10% Owner) | Buy | 1,176,470 | 8.50 | 9,999,995 |
| 2018-03-12 | Thompson Peter A. | Buy | 588,235 | 8.50 | 4,999,997 |
| 2018-03-12 | Adams Street Partners Llc | Buy | 588,235 | 8.50 | 4,999,997 |
| 2018-03-12 | Miller Richard A Md (President and CEO) | Buy | 100,000 | 8.50 | 850,000 |
| 2017-11-20 | Miller Richard A Md (President and CEO) | Buy | 10,000 | 10.79 | 107,850 |
| 2017-06-23 | Novo Holdings A/s (10% Owner) | Buy | 20,000 | 10.95 | 219,000 |
| 2017-06-13 | Miller Richard A Md (President and CEO) | Buy | 5,000 | 9.95 | 49,725 |
| 2017-06-12 | Miller Richard A Md (President and CEO) | Buy | 11,216 | 9.82 | 110,185 |
| 2017-06-09 | Miller Richard A Md (President and CEO) | Buy | 8,784 | 9.92 | 87,137 |
| 2016-06-24 | Thompson Peter A. | Buy | 900 | 12.99 | 11,691 |
| 2016-06-24 | Isaly Samuel D | Buy | 900 | 12.99 | 11,691 |
| 2016-06-23 | Thompson Peter A. | Buy | 100 | 12.92 | 1,292 |
| 2016-06-23 | Isaly Samuel D | Buy | 100 | 12.92 | 1,292 |
| 2016-06-21 | Thompson Peter A. | Buy | 26,083 | 12.87 | 335,688 |
| 2016-06-21 | Isaly Samuel D | Buy | 26,083 | 12.87 | 335,688 |
| 2016-06-17 | Thompson Peter A. | Buy | 12,300 | 12.48 | 153,504 |
| 2016-06-17 | Isaly Samuel D | Buy | 12,300 | 12.48 | 153,504 |
| 2016-06-16 | Thompson Peter A. | Buy | 5,000 | 12.04 | 60,199 |
| 2016-06-16 | Isaly Samuel D | Buy | 5,000 | 12.04 | 60,199 |
| 2016-06-15 | Thompson Peter A. | Buy | 5,000 | 11.94 | 59,700 |
| 2016-06-15 | Isaly Samuel D | Buy | 5,000 | 11.94 | 59,700 |
| 2016-06-14 | Thompson Peter A. | Buy | 10,000 | 12.71 | 127,100 |
| 2016-06-14 | Isaly Samuel D | Buy | 10,000 | 12.71 | 127,100 |
| 2016-06-10 | Thompson Peter A. | Buy | 20,000 | 12.98 | 259,600 |
| 2016-06-10 | Isaly Samuel D | Buy | 20,000 | 12.98 | 259,600 |
| 2016-06-09 | Thompson Peter A. | Buy | 30,000 | 12.95 | 388,500 |
| 2016-06-09 | Isaly Samuel D | Buy | 30,000 | 12.95 | 388,500 |
| 2016-05-20 | Thompson Peter A. | Buy | 4,716 | 13.09 | 61,732 |
| 2016-05-20 | Isaly Samuel D | Buy | 4,716 | 13.09 | 61,732 |
| 2016-05-19 | Thompson Peter A. | Buy | 2,600 | 12.43 | 32,318 |
| 2016-05-19 | Isaly Samuel D | Buy | 2,600 | 12.43 | 32,318 |
| 2016-05-18 | Thompson Peter A. | Buy | 4,200 | 11.55 | 48,510 |
| 2016-05-18 | Isaly Samuel D | Buy | 4,200 | 11.55 | 48,510 |
| 2016-03-29 | Gould Terry P (Director) | Buy | 200,000 | 15.00 | 3,000,000 |
| 2016-03-29 | Novo A/s (10% Owner) | Buy | 666,666 | 15.00 | 9,999,990 |
| 2016-03-29 | Thompson Peter A. (Director) | Buy | 550,000 | 15.00 | 8,250,000 |
| 2016-03-29 | Adams Street Partners Llc (10% Owner) | Buy | 200,000 | 15.00 | 3,000,000 |
| 2016-03-29 | Orbimed Advisors Llc (Director) | Buy | 550,000 | 15.00 | 8,250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Corvus Pharmaceuticals, Inc. (symbol CRVS, CIK number 1626971) see the Securities and Exchange Commission (SEC) website.